Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01485861
Title Study of GDC-0068 Or GDC-0980 With Abiraterone Acetate Versus Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications

prostate adenocarcinoma

Therapies

GDC-0980

Abiraterone

Ipatasertib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP


No variant requirements are available.